Investing $1,000 a month with an average total return of 12% per annum would grow into $2.15 million after 27 years. That ...

Let's run the numbers and see how much an Australian investor would need in their superannuation fund to live off $65,000 a ...

Up 25% in 12 months, a leading fundie sees strong ongoing growth potential for this S&P/ASX 300 Index (ASX: XKO) stock.

Last week, the broker reaffirmed its buy rating and $40.20 price target on the ASX 200 share. This implies potential upside ...

The S&P/ASX 200 Index (ASX: XJO) is up 3% in 2025, with these three ASX 200 stocks doing a lot of the heavy lifting.

Kogan.com Ltd (ASX: KGN) and Regis Resources Ltd (ASX: RRL) are two of four ASX shares falling on Friday. Here's ...

This S&P/ASX 300 Index (ASX: XKO) tech stock has delivered by strong returns in the last few years. Here’s why there could be ...

ASX healthcare stocks are in the green on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) currently 0.41% higher.

We reveal the forecast dividend amounts and dividend yields that analysts expect the largest ASX 200 financial shares to pay ...

The All Ordinaries Index (ASX: XAO) is up 0.32% today, but this ASX share is leaving those gains in the dust. Here’s what’s ...

The AMP Ltd (ASX: AMP) share price just leapt to new multi-year highs. Here’s what’s happening with the ASX 200 financial ...

Goldman has a buy rating and $40.20 price target on its shares. Another ASX 200 share that is being described as a fallen ...